Weight Loss Drug Linked to Blindness Risk
2024-12-17
Two new studies show that long-term use of antidiabetic drug semaglutide, sold under brand names Ozempic and Wegovy among others, increase the risk of blindness.
Two new studies show that long-term use of antidiabetic drug semaglutide, sold under brand names Ozempic and Wegovy among others, increase the risk of blindness.